# A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®

> **NCT02007356** · PHASE2 · RECRUITING · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 30 (estimated)

## Conditions studied

- Adenovirus Infection
- EBV
- Cytomegalovirus Infections
- Cytokine Capture System
- Allogenic Disease

## Interventions

- **BIOLOGICAL:** IFN-γ positive selected T-cells

## Key facts

- **NCT ID:** NCT02007356
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2014-12
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02007356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02007356, "A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02007356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*